CJC-1295/Ipamorelin 10mg
Frequently Bought Together
Complete Your Research Setup
Bacteriostatic water is required to reconstitute lyophilized peptides before use.
What You Should Know
Two peptides working together for bigger results
CJC-1295 tells your body to make more growth hormone while Ipamorelin tells it to release more. Together, they produce a much greater effect than either one alone.
Long-lasting growth hormone elevation
CJC-1295 keeps working for days instead of hours, providing a sustained, natural-feeling boost in growth hormone levels.
Better sleep, skin, and recovery
Research subjects report deeper sleep, faster recovery from physical stress, improved skin quality, and increased energy — all downstream benefits of optimized growth hormone.
A synergistic combination of two GH-releasing peptides that work through complementary pathways for amplified growth hormone output.
CJC-1295 (a GHRH analog) tells the pituitary to make more growth hormone, while Ipamorelin (a ghrelin mimetic) tells it to release more. Together, they produce a significantly greater GH response than either alone.
CJC-1295 has an extended half-life, providing sustained GH elevation over days rather than hours, creating a more natural pulsatile release pattern.
Research subjects have reported improved sleep depth, faster recovery from physical stress, better skin quality, and enhanced overall vitality — all downstream effects of optimized growth hormone levels.
Quality: ≥99% (HPLC) · Third-party tested
All Elystra Bio products are third-party tested for identity, purity, and potency. Certificates of analysis are available upon request.
Dual GH-axis blend — synergistic growth hormone research.
“CJC-1295/Ipamorelin is a synergistic combination of two complementary growth hormone axis peptides. CJC-1295 (a GHRH analog with Drug Affinity Complex) provides sustained GH-releasing activity, while Ipamorelin (a selective GHS-R agonist) offers pulsatile GH amplification. Together they represent a dual-pathway approach to growth hormone research.”
Description
CJC-1295/Ipamorelin is a synergistic combination of two complementary growth hormone axis peptides. CJC-1295 (a GHRH analog with Drug Affinity Complex) provides sustained GH-releasing activity, while Ipamorelin (a selective GHS-R agonist) offers pulsatile GH amplification. Together they represent a dual-pathway approach to growth hormone research.
Related products
-
Research Profile
A synthetic tetrapeptide studied for telomerase activation and longevity research.
≥99% (HPLC) · Third-party tested
Epithalon 10mg
Research Use Only $39.99 Add to cart -
Research Profile
Elystra Bio’s proprietary dual-peptide repair blend combining BPC-157 (10mg) and TB-500 (10mg) for comprehensive recovery research.
≥99% (HPLC) · Third-party tested
Wolverine 20mg
Research Use Only $109.99 Add to cart -
Research Profile
An ERRα agonist being researched as an “exercise mimetic” — a compound that activates some of the same pathways as physical exercise.
≥98% (HPLC) · Third-party tested
SLU-PP-332 5mg
Research Use Only $64.99 Add to cart -
Research Profile
A synthetic ACTH analog developed for neuroprotection, cognitive enhancement, and brain health research.
≥99% (HPLC) · Third-party tested
Semax 5mg
Research Use Only $39.99 Add to cart
For research purposes only. Not for human consumption. All products are third-party tested.
Reviews
There are no reviews yet.